Tenderwize
Zurück zur Suche

Optimize early Hit Structures through iterative DMTA Cycles using Advanced Medicinal Chemistry

Katholieke Universiteit te Leuven·Leuven, Belgium·Deadline Aug 10, 2026 · 6 days left·Neg W Call·Services
Structured notice only
Originaltitel der Bekanntmachung

Belgium – Research and experimental development services – QMMO26-4194 - Appointment of a CRO to optimize early Hit Structures through iterative DMTA Cycles (Design – Make – Test – Analysis) using Advanced Medicinal Chemistry

30/100

Opportunity Score

Needs reviewMedium complexity
ServicesOpen
Warum diese Bewertung?

Chance

30 / 100

Komplexität

50 / 100

Risikofaktoren

No estimated contract value or budget disclosed. Bidders cannot assess financial attractiveness or resource commitment.

Structured data flags EU funding, but XML notice states 'no-eu-funds'. This may affect contract terms and conditions.

Submission deadline in 6 days

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Services contract
  • 1 lot
  • Duration 1 YEAR
  • Perform iterative Design-Make-Test-Analyze (DMTA) cycles for optimization of early hit structures.
  • Apply advanced medicinal chemistry techniques.
Vollständige Zusammenfassung anzeigen

Single-lot negotiated procedure for appointing a Contract Research Organization (CRO) to optimize early hit structures through iterative Design-Make-Test-Analyze (DMTA) cycles in advanced medicinal chemistry. The buyer is KU Leuven, acting for itself and VIB. The contract duration is 1 year. No estimated value is provided. The procedure is a competitive negotiation without prior call (neg-w-call), likely limiting candidates to 3-4. Award criteria (price and quality) will be detailed in the second stage. The tender is published in English, with submission via the e-procurement platform. EU funding status is inconsistent: structured data indicates EU-funded, but the XML notice states no EU funds.

Risiken

No estimated contract value or budget disclosed. Bidders cannot assess financial attractiveness or resource commitment.

Structured data flags EU funding, but XML notice states 'no-eu-funds'. This may affect contract terms and conditions.

Submission deadline in 6 days

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • CRO must be capable of conducting advanced medicinal chemistry DMTA cycles.

Administrative

  • Electronic submission via the e-procurement platform is required.
  • Tender must be submitted in English (notice language).

Anforderungen können unvollständig sein.

Zuschlagskriterien

Lot 1

Price (weight not specified)Quality (weight not specified)

Auftraggeber

Ort

Leuven, BEL

Auftraggeberprofil

Profil öffnen

Kennung

0419052173_5132

Tätigkeit

Education

Lose (1)

LOT-0001

Optimize early Hit Structures through iterative DMTA Cycles using Advanced Medicinal Chemistry

Appointment of a CRO to perform iterative DMTA cycles (Design-Make-Test-Analyze) for optimizing early hit structures in advanced medicinal chemistry. The contract is for services related to research and experimental development (CPV 73100000). Duration: 1 year. Place of performance: Leuven, Belgium (BE242).

ServicesEU fundedElectronic submission

Ort

BE242, Belgium

Dauer

1 YEAR

Kategorie

Research

Zuschlagskriterien

Best price-quality ratio

Frist

Deadline Aug 10, 2026

Vergabedetails

Veröffentlichungsdatum
08 Jul 2026
Sprachen
Dutch, English

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
473822-2026

Dokumente (2)

Ähnliche Ausschreibungen